Göran Westerberg

An exploratory double‐blind, randomized clinical trial with selisistat, a <scp>SirT1</scp> inhibitor, in patients with <scp>H</scp>untington's disease

Sigurd D. Süßmuth, Salman Haider, G. Bernhard Landwehrmeyer et al. · British Journal of Clinical Pharmacology · 2014 · 164 citations · Full text

Medicine, Neurology, Pharmacology +17

A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease

M.R. Smith, Adeela Syed, Tamás Lukácsovich et al. · Human Molecular Genetics · 2014 · 144 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers*

Johann Valtysson, Karl‐Johan Lindner, Jens D. Kristensen et al. · Clinical Pharmacology & Therapeutics · 1995 · 119 citations

Medicine, Neuroscience, Pharmacology +10

Brain Networks Affected by Synchronized Sleep Visualized by Positron Emission Tomography

Jesper Andersson, Hirotaka Onoe, Jerker Hetta et al. · Journal of Cerebral Blood Flow & Metabolism · 1998 · 112 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease

Richard Torstenson, Per Hartvig, Bengt Långström et al. · Annals of Neurology · 1997 · 88 citations

Life Sciences, Neuroscience, Pharmacology +17